Showing results 1 to 1 of 1
| Issue Date | Title | Journal Title |
|---|---|---|
| 2025 | Feasibility of circulating tumor DNA as a marker for treatment response to triplet maintenance therapy with olaparib, pembrolizumab, and bevacizumab, and prognosis in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer | Dissertation |